NVS

NovartisC

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

In line

vs peer average

NVS vs peer average

45/100

NVS vs. peer average (C vs. C)

Grade spread

A 1 · B 3 · C 4 · F 1

Graded peers loaded

Coverage

9 graded

100% of tracked

Peer overview

PFE is the first available peer comparator.

US large-cap pharma with broad portfolio and recent R&D cadence changes; useful comparator for commercialization scale.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerPFEPfizer

NVS

Novartis

PFE

Pfizer

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs PFE

NVS / PFE

Grade Position

In line

NVS vs. peer average (C vs. C)

45/100

Momentum

NVS

Value

NVS

Sentiment

PFE

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs NVS

PFE

60/100

Even

AZN

20/100

SNY

60/100

Even

MRK

Merck & Co Inc Common

80/100

-1

NVO

Novo Nordisk A/S Class B ADR

100/100

-2

PFE is the first peer returned for this comparison set.